Exhibit 5.1
| | | | |
Contact | | Craig Semple | | |
| | T +61 3 8656 3349 |
| | csemple@gtlaw.com.au |
Our ref | | CXS:1041902 |
| | | | 101 Collins Street |
| | | | Melbourne VIC 3000 |
| | | | T: +61 3 8656 3300 F: +61 3 8656 3400 www.gtlaw.com.au |
9 October 2020
The Directors
Opthea Limited
Level 4, 650 Chapel Street
South Yarra VIC 3141
Dear Directors
Opthea Limited – Registration Statement on Form F-1
We have acted as Australian legal counsel to Opthea Limited (Company), a company incorporated under the laws of the Commonwealth of Australia, in connection with its filing of a registration statement on Form F-1 (Registration Statement) under the U.S. Securities Act of 1933, as amended (Securities Act), with the U.S. Securities and Exchange Commission (Commission).
The Registration Statement relates to the public offering by the Company, as set out in the prospectus forming part of the Registration Statement (Prospectus) of up to 10,695,000 American Depositary Shares (ADS) (including 1,395,000 ADSs to cover over-allotments (if any)) to be issued and sold by the Company. Each of the ADSs represents eight fully paid ordinary shares in the Company (Shares).
The Registration Statement, including the Prospectus, is referred to in this letter collectively (and unless the context requires otherwise) as the Documents.
1 | Documents examined and searches conducted and relied on by us |
For the purposes of this opinion, we have examined and relied on copies of the following documents:
(a) | the Registration Statement; |
(b) | a draft of the Prospectus; |
(c) | the Company’s Constitution; |
(d) | draft minutes of meeting and resolutions of the Board of Directors dated 17 July 2020, 24 September 2020 and 9 October 2020 and |
(e) | a search obtained from the Australian Securities and Investments Commission as at 9 October 2020. |